DZ Bank’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-110,113
Closed -$6.63M 1075
2023
Q4
$6.63M Hold
110,113
0.01% 421
2023
Q3
$7.4M Hold
110,113
0.01% 393
2023
Q2
$7.6M Buy
110,113
+2,587
+2% +$169K 0.01% 400
2023
Q1
$5.18M Buy
+107,526
New +$5.26M 0.01% 450
2022
Q4
Sell
-76,624
Closed -$3.13M 1066
2022
Q3
$3.13M Buy
76,624
+39,603
+107% +$1.86M 0.01% 506
2022
Q2
$2.04M Buy
+37,021
New +$1.56M ﹤0.01% 602

Other funds holding LEGN

DZ Bank's LEGN Position: Q1 2024 in Review

DZ Bank sold out of Legend Biotech (LEGN) in Q1 2024, closing a stake of 110,113 shares — an estimated $6.63M sold.

DZ Bank first reported a position in LEGN in Q2 2022 and held it in 6 quarters. The position peaked at $7.6M in Q2 2023. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • DZ Bank reported no remaining Legend Biotech position as of Q1 2024 after selling out during the quarter.
  • DZ Bank sold 110,113 Legend Biotech shares in Q1 2024, an estimated $6.63M.
  • DZ Bank first reported a position in Legend Biotech in Q2 2022 and held it in 6 quarters.
  • DZ Bank's Legend Biotech position peaked at $7.6M in Q2 2023.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on DZ Bank's 13F filing for Q1 2024, filed 15 May 2024.